Six analysts have recently updated their ratings on Accenture (NYSE:ACN), with varying perspectives from bullish to bearish. The average 12-month price target is now $375.5, an 8.68% increase from the previous $345.50. Analysts from firms like Morgan Stanley, BMO Capital, UBS, Wedbush, and Redburn Atlantic have raised their price targets, indicating a positive outlook on Accenture's performance. The company has shown strong financial health with a market capitalization above industry average, a revenue growth rate of 3.03%, a net margin of 12.16%, an ROE of 7.54%, an ROA of 3.84%, and a low debt-to-equity ratio of 0.12.